Tesla
TSLA
NVIDIA
NVDA
Alibaba
BABA
4
Super Micro Computer
SMCI
5
Tempus AI
TEM
US Stock MarketDetailed Quotes
NRSN NeuroSense Therapeutics
- 1.070
- -0.015-1.36%
Close Feb 25 16:00 ET
- 1.079
- +0.009+0.87%
Post 19:15 ET
24.85MMarket Cap-1.41P/E (TTM)
1.110High1.024Low93.19KVolume1.100Open1.085Pre Close98.80KTurnover0.82%Turnover RatioLossP/E (Static)23.23MShares2.29052wk High-8.84P/B12.16MFloat Cap0.51252wk Low--Dividend TTM11.37MShs Float8.180Historical High--Div YieldTTM7.92%Amplitude0.400Historical Low1.060Avg Price1Lot Size
NeuroSense Therapeutics News
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
NeuroSense Therapeutics | 20-F: FY2023 Annual Report
NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
NeuroSense Therapeutics | 20-F: FY2022 Annual Report
NeuroSense Therapeutics | 6-K/A: Report of foreign private issuer (related to financial reporting)
NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
NeuroSense Therapeutics | 20-F: Registration statement / Annual report / Transition report